Stocks to buy today: Mirae Asset Sharekhan sees up to 40% upside in Bajaj Finserv

economictimes.indiatimes.com:

Medplus Health Services, highlighting its robust expansion plans and promising growth in the generics segment.

Mirae Asset Sharekhan has issued a 'Buy' rating on Bajaj Finserv, citing its ambitious long-term strategy and focus on leveraging AI for profitable growth.

Meanwhile, Hem Securities has recommended a 'Buy' on Parag Milk, driven by its strong earnings growth, robust distribution network, and focus on value-added products.

We have collated a list of recommendations from top brokerage firms, sourced from ETNow and other platforms:

Investec on Medplus Health Services: Buy | Target: Rs 940 | LTP: Rs 844 | Upside: 11%

Investec has maintained a «Buy» rating on Medplus Health Services with a target price of Rs 940, indicating an upside potential of 11% from the current market price of Rs 844.

• Stock Trading

  Macroeconomics Made Easy: Online Certification Course

  By — Anirudh Saraf, Founder- Saraf A & Associates, Chartered Accountant

• Stock Trading

  Introduction to Technical Analysis & Candlestick Theory

  By — Dinesh Nagpal, Full Time Trader, Ichimoku & Trading Psychology Expert

• Stock Trading

  Options Scalping Made Easy

  By — Sivakumar Jayachandran, Ace Scalper

• Stock Trading

  Derivative Analytics Made Easy

  By — Vivek Bajaj, Co Founder- Stockedge and Elearnmarkets

• Stock Trading

  Advanced Strategies in Stock Market Mastery

  By — CA Raj K Agrawal, Chartered Accountant

• Stock Trading

  Markets 102: Mastering Sentiment Indicators for Swing and Positional Trading

  By — Rohit Srivastava, Founder- Indiacharts.com

• Stock Trading

  Cryptocurrency